Securities Code: 002332 Securities Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-021
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Participating in the 2026 Online Investor Reception Day for Listed Companies in Zhejiang and the 2025 Performance Briefing
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
To further strengthen interactive communication with investors, Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will participate in the "2026 Online Investor Reception Day for Listed Companies in Zhejiang and the 2025 Performance Briefing" organized by the Zhejiang Listed Companies Association and undertaken by Shenzhen All-Round Network Co., Ltd., under the guidance of the Zhejiang Securities Regulatory Bureau. The relevant matters are hereby announced as follows:
This event will be held remotely online. Investors can log in to the "All-Round Roadshow" website (https://rs.p5w.net), follow the WeChat official account "All-Round Finance," or download the All-Round Roadshow APP to participate in this interactive exchange. The event will be held on Wednesday, May 13, 2026, from 15:00 to 17:00. Mr. Zhang Yusong, Chairman of the Company, Mr. Jin Weihua, General Manager, Ms. Fu Qun, Independent Director, Ms. Wang Yaohua, Chief Financial Officer, and Mr. Zhang Wangwei, Deputy General Manager and Secretary of the Board (participants may be adjusted in case of special circumstances), will be online to communicate and exchange with investors on issues of investor concern, including the Company's 2025 performance, corporate governance, development strategy, and operating conditions.